Pure Global
NCT05193864

Office-based Validation of the JVPHome

Eastern Regional Health Authority·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Congestive Heart Failure
Drug/Device/Intervention
Device: JVPHome and ultrasound
Study type
Observational
Intervention type
device
Sponsor & location
Primary sponsor
Eastern Regional Health Authority
Location
St. John's, Canada
Timeline & enrollment
Phase
N/A
Start date
Nov 29, 2021
End date
Jan 03, 2023
Enrollment
60 participants
Primary outcome

Accuracy of JVP assessment using the JVPHome

Summary

The JVPHome is a novel medical device that utilizes machine vision in order to facilitate
 assessment of jugular venous pressure (JVP) height relative to the sternal angle with the
 ultimate goal of enabling remote JVP monitoring. The current study aims to evaluate the
 ability of an enhanced version of the JVPHome to enable remote identification of JVP height
 relative to ultrasound among congestive heart failure (CHF) patients when the device is
 applied by the study team in the clinic.

ICD-10 classifications
Congestive heart failureHeart failureHypertensive heart disease with (congestive) heart failureHypertensive heart and renal disease with (congestive) heart failureHeart failure, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05193864
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05193864 through Pure Global AI's free database. This phase not specified trial is sponsored by Eastern Regional Health Authority and is currently Recruiting. The study focuses on Congestive Heart Failure. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.